RESMAIN (FL)

RESMAIN (FL)

A Multicentre, Double Blind, Randomised, Placebo-controlled, Phase II Trial to Evaluate Resminostat for Maintenance Treatment of Patients With Advanced Stage (Stage IIB-IVB) Mycosis Fungoides (MF) or S├ęzary Syndrome (SS) That Have Achieved Disease Control With Systemic Therapy - the RESMAIN Study


Study Treatments


Inclusion criteria


Exclusion criteria


Participating sites

Link